These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 554555)

  • 21. [On the presence of anti-rubella immunity in a population of Florence province (author's transl)].
    Gagliardi C; Gagliardi M
    Ann Sclavo; 1977; 19(3):347-56. PubMed ID: 607878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical trials carried out to assess non-parenteral routes for administration of Wistar RA 27/3 strain live attenuated rubella vaccine.
    Freestone DS
    Dev Biol Stand; 1976; 33():237-40. PubMed ID: 782973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reducing the global burden of congenital rubella syndrome: report of the World Health Organization Steering Committee On Research Related To Measles and Rubella Vaccines and Vaccination, June 2004.
    Best JM; Castillo-Solorzano C; Spika JS; Icenogle J; Glasser JW; Gay NJ; Andrus J; Arvin AM
    J Infect Dis; 2005 Dec; 192(11):1890-7. PubMed ID: 16267759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Rubella screening and directed vaccination of 14-year-old girls with live rubella vaccine RA 27/3 in the Liberec district].
    Strauss J; Zikmundová V; Stovicek Z; Zikmund V; Téminová V; Langhammer O; Kokesová O
    Cesk Epidemiol Mikrobiol Imunol; 1982 Sep; 31(5):266-76. PubMed ID: 6215992
    [No Abstract]   [Full Text] [Related]  

  • 25. Postpartum immunization with rubella virus vaccine and antibody response in breast-feeding infants.
    Krogh V; Duffy LC; Wong D; Rosenband M; Riddlesberger KR; Ogra PL
    J Lab Clin Med; 1989 Jun; 113(6):695-9. PubMed ID: 2732617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
    Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M
    An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Problems of rubella prevention: vaccination of 51 fertile young women with the Wister Ra 27/3 virus strain].
    Russo F; Piro E; Frugiuele PL; Buffone E; Palma B; Greco LM
    Ann Sclavo; 1980; 22(1):57-62. PubMed ID: 7247485
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevalence of HI antibody titer against rubella virus to determine the effect of mass vaccination in Tehran.
    Soleimanjahi H; Bamdad T; Fotouhi F; Roustai MH; Faghihzadeh S
    J Clin Virol; 2005 Oct; 34(2):153-4. PubMed ID: 16076562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of the specific immune response after anti-rubella vaccination].
    Cellesi C; Rossolini A; Rossolini GM; Bianchi Bandinelli ML; Cusi MG; Egisto Valensin P
    Quad Sclavo Diagn; 1988; 24(1-4):97-105. PubMed ID: 3268925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An evaluation of immunization against rubella.
    Mountifield J
    Prim Care; 1978 Dec; 5(4):717-23. PubMed ID: 253369
    [No Abstract]   [Full Text] [Related]  

  • 31. [Seroimmunity against rubella 5 years after immunisation with Cendehill vaccine (author's transl)].
    Sarateanu DE; Ehrengut W
    Immun Infekt; 1975 Apr; 3(2):51-3. PubMed ID: 1184096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rubella immune status in general practice.
    Yelland MJ
    Aust Fam Physician; 1989 Oct; 18(10):1279-81, 1284-5. PubMed ID: 2818317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Investigations on the dependency of hemagglutination inhibition titers against rubella virus on the number and quality of antibody molecules (author's transl)].
    Hoppe G
    Zentralbl Bakteriol A; 1981; 249(2):143-51. PubMed ID: 7269848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rubella virus vaccine.
    Pediatrics; 1969 Jul; 44(1):21-3. PubMed ID: 5795400
    [No Abstract]   [Full Text] [Related]  

  • 35. [Rubella immunization--immunity after 4 years (author's transl)].
    Petersen EE; Neumann-Haefelin D; Kärnbach M; Haas R
    Dtsch Med Wochenschr; 1977 Jul; 102(26):954-8. PubMed ID: 885075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Humoral immune response after primary rubella virus infection and after vaccination.
    Vauloup-Fellous C; Grangeot-Keros L
    Clin Vaccine Immunol; 2007 May; 14(5):644-7. PubMed ID: 17344342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Intranasal vaccination against rubella (author's transl)].
    Hofmann K; Karsai I; Golob E; Kunz C
    Wien Klin Wochenschr; 1974 Apr; 86(7):189-90. PubMed ID: 4822330
    [No Abstract]   [Full Text] [Related]  

  • 38. Rubella-immunity gap: Is intranasal vaccination the answer?
    Banatvala JE; Best JM; O'Shea S; Harcourt GC
    Lancet; 1979 May; 1(8123):970. PubMed ID: 87629
    [No Abstract]   [Full Text] [Related]  

  • 39. [Immunity and anti-rubella vaccination].
    Delville JP; Tellini-Emma M
    Arch Belg Med Soc; 1970 May; 28(5):321-30. PubMed ID: 5494764
    [No Abstract]   [Full Text] [Related]  

  • 40. [Rubella vaccination: Possibilites, application, side-effects].
    Grassi M
    Clin Ter; 1971 Jul; 58(2):151-8. PubMed ID: 5157283
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.